Radiation Oncology/Therapy: Page 265

IsoRay wraps up feasibility study
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical has finished an initial feasibility study for the use of its cesium-131 brachytherapy seeds in accelerated partial-breast irradiation procedures.
October 26, 2010
Calypso launches clinical study
By AuntMinnie.com staff writers
Electromagnetic localization technology developer Calypso Medical Technologies has commenced the first clinical study evaluating its Calypso system for lung cancer radiation therapy tracking.
October 26, 2010
Mirada signs R&D deal with Moffitt
By AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical has finalized an agreement with Moffitt Cancer Center in Tampa, FL.
October 26, 2010
PSA screening, aspirin may reduce prostate cancer deaths
By Cynthia E. Keen
Screening men who have been treated for prostate cancer based on prostate-specific antigen (PSA) levels can lower deaths by reducing the risk of metastasis within 10 years of treatment, according to a study to be presented at the upcoming American Society for Radiation Oncology meeting in San Diego.
October 25, 2010
Mirada touts workflow gains at ASTRO
By AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical will be presenting a range of treatment planning applications at next week's American Society for Radiation Oncology (ASTRO) annual conference in San Diego.
October 25, 2010
Vision RT signs on Varian
By AuntMinnie.com staff writers
U.K. radiation therapy software developer Vision RT has inked a distribution agreement with radiation therapy firm Varian Medical Systems.
October 24, 2010
Radiation boosts hormone therapy for prostate cancer patients
By Cynthia E. Keen
High-risk prostate cancer patients who have radiation added to their regimen of androgen deprivation therapy have an improved chance of survival compared with patients who only get hormone therapy, according to a study to be presented at next week's American Society for Radiation Oncology meeting in San Diego.
October 24, 2010
Elekta brings VMAT to India
By AuntMinnie.com staff writers
Oncology firm Elekta said that Medanta Cancer Institute in New Delhi is the first institution in India to utilize its volumetric-modulated arc therapy (VMAT) technology.
October 24, 2010
GE to buy Clarient for $580M
By AuntMinnie.com staff writers
GE Healthcare has entered a definitive agreement to acquire advanced oncology testing and diagnostic services firm Clarient in a transaction valued at $580 million.
October 21, 2010
NRC to hear thyroid cancer therapy concerns
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) will hold public hearings in Washington, DC; Los Angeles; and Houston over the next several weeks on radiation safety in healthcare, including outpatient treatment of patients with thyroid cancer.
October 21, 2010
Shortage of rad oncologists predicted in 2010-2020
By Cynthia E. Keen
The demand for radiation therapy treatment in the U.S. between 2010 and 2020 is expected to increase at a rate 10 times faster than the increase in practicing radiation oncologists, according to new research published online October 18 in the Journal of Clinical Oncology.
October 20, 2010
Low-risk prostate cancer patients choose surveillance in U.K.
By Cynthia E. Keen
Thousands of men in the U.K. diagnosed with low-risk localized prostate cancer are delaying aggressive treatment, according to a new study in the October issue of BJU International. Instead, they are opting for active surveillance that includes monitoring and testing of prostate-specific antigen levels.
October 20, 2010
Previous Page
Page 265 of 468
Next Page